Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

N-Acetylserotonin

From Wikipedia, the free encyclopedia
N-Acetylserotonin
Names
Preferred IUPAC name
N-[2-(5-Hydroxy-1H-indol-3-yl)ethyl]acetamide
Other names
NAS;N-Acetyl-5-hydroxytryptamine; 5-Hydroxy-N-acetyltryptamine;N-Acetyl-5-HT; 5-HO-NAcT; 5-OH-NAcT
Identifiers
3D model (JSmol)
ChEBI
ChEMBL
ChemSpider
DrugBank
ECHA InfoCard100.013.560Edit this at Wikidata
MeSHN-AcetylserotoninN-Acetylserotonin
UNII
  • InChI=1S/C12H14N2O2/c1-8(15)13-5-4-9-7-14-12-3-2-10(16)6-11(9)12/h2-3,6-7,14,16H,4-5H2,1H3,(H,13,15) checkY
    Key: MVAWJSIDNICKHF-UHFFFAOYSA-N checkY
  • InChI=1/C12H14N2O2/c1-8(15)13-5-4-9-7-14-12-3-2-10(16)6-11(9)12/h2-3,6-7,14,16H,4-5H2,1H3,(H,13,15)
    Key: MVAWJSIDNICKHF-UHFFFAOYAX
  • CC(=O)NCCC1=CNC2=C1C=C(C=C2)O
Properties
C12H14N2O2
Molar mass218.256 g·mol−1
Density1.268 g/mL
Except where otherwise noted, data are given for materials in theirstandard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)
Chemical compound

N-Acetylserotonin (NAS), also known asnormelatonin, is anaturally occurring chemicalintermediate in theendogenous production ofmelatonin fromserotonin.[1][2] It also hasbiological activity in its own right, including acting as amelatonin receptor agonist, anagonist of theTrkB, and havingantioxidant effects.

Biological function

[edit]

Like melatonin, NAS is anagonist at themelatonin receptorsMT1,MT2, andMT3, and may be considered to be aneurotransmitter.[3][4][5][6] In addition, NAS is distributed in some areas of thebrain where serotonin and melatonin are not, suggesting that it may have unique central duties of its own instead of merely functioning as aprecursor in thesynthesis of melatonin.[3] NAS is known to have anti-depressant, neurotrophic and cognition-enhancing effects[7][8] and has been proposed to be a target for the treatment of aging-associated cognitive decline and depression[8]

TrkB receptor

[edit]

NAS has been shown to act as apotentTrkB receptor agonist, while serotonin and melatonin do not.[3] Subchronic and chronic administration of NAS to adult mice induces proliferation of neuralprogenitor cells (NPC)s, blockage of TrkB abolished this effect suggesting that it is TrkB-dependent.[9] NAS was also found to significantly enhance NPC proliferation in sleep-deprived mice.[9] It is thought that the anti-depressant and neurotrophic effects of NAS are in part due to its role as a TrkB agonist.[7]

Antioxidant properties

[edit]

NAS acts as a potentantioxidant, NAS effectiveness as an anti-oxidant has been found to be different depending on the experimental model used, it has been described as being between 5 and 20 times more effect than melatonin at protecting against oxidant damage.[10] NAS has been shown to protect againstlipid peroxidation in microsomes and mitochondria.[11] NAS has also been reported to lower resting levels ofROS in peripheral blood lymphocytes and to exhibit anti-oxidant effects against t-butylated hydroperoxide- and diamide-induced ROS.[12] NAS has also been observed to inhibitnitric oxide synthase.[13]

Anti-inflammatory effects

[edit]

NAS has been reported to haveanti-inflammatory effects. NAS has been shown to inhibitLPS-stimulated production of theproinflammatory cytokineTNF-alpha in differentiated THP-1-derived human monocytes.[14]

Miscellaneous

[edit]

NAS may play a role in the antidepressant effects ofselective serotonin reuptake inhibitors (SSRIs) andmonoamine oxidase inhibitors (MAOIs).[3] The SSRIfluoxetine and theMAO-AinhibitorclorgylineupregulateAANAT indirectly throughserotonergic mechanisms and thereby increase NAS levels after chronic administration, and this correlates with the onset of their antidepressant effects.[3][15] Furthermore, light exposure inhibits the synthesis of NAS and reduces the antidepressant effects of MAOIs.[3] In addition, AANATknockout mice display significantly greater immobility times versus control mice inanimal models ofdepression.[3] These data support a potential role for NAS in mood regulation and in antidepressant-induced therapeutic benefits.

Through a currently unidentified mechanism, NAS may be the cause of theorthostatic hypotension seen with clinical treatment of MAOIs.[15][16] It reducesblood pressure in rodents, andpinealectomy (thepineal gland being a major site of NAS and melatonin synthesis) abolishes thehypotensive effects ofclorgyline.[15][16]

Biochemistry

[edit]

NAS is produced from serotonin by theenzymearalkylamineN-acetyltransferase (AANAT) and is converted to melatonin byacetylserotoninO-methyltransferase (ASMT).

NAS is able to penetrate theblood–brain barrier, unlike serotonin.[17]

See also

[edit]

References

[edit]
  1. ^AXELROD J, WEISSBACH H (April 1960). "Enzymatic O-methylation of N-acetylserotonin to melatonin".Science.131 (3409): 1312.Bibcode:1960Sci...131.1312A.doi:10.1126/science.131.3409.1312.PMID 13795316.S2CID 22341451.
  2. ^WEISSBACH H, REDFIELD BG, AXELROD J (September 1960). "Biosynthesis of melatonin: enzymic conversion of serotonin to N-acetylserotonin".Biochimica et Biophysica Acta.43:352–3.doi:10.1016/0006-3002(60)90453-4.PMID 13784117.
  3. ^abcdefgJang SW, Liu X, Pradoldej S, et al. (February 2010)."N-acetylserotonin activates TrkB receptor in a circadian rhythm".Proceedings of the National Academy of Sciences of the United States of America.107 (8):3876–81.Bibcode:2010PNAS..107.3876J.doi:10.1073/pnas.0912531107.PMC 2840510.PMID 20133677.
  4. ^Zhao H, Poon AM, Pang SF (March 2000). "Pharmacological characterization, molecular subtyping, and autoradiographic localization of putative melatonin receptors in uterine endometrium of estrous rats".Life Sciences.66 (17):1581–91.doi:10.1016/S0024-3205(00)00478-1.PMID 11261588.
  5. ^Nonno R, Pannacci M, Lucini V, Angeloni D, Fraschini F, Stankov BM (July 1999)."Ligand efficacy and potency at recombinant human MT2 melatonin receptors: evidence for agonist activity of some mt1-antagonists".British Journal of Pharmacology.127 (5):1288–94.doi:10.1038/sj.bjp.0702658.PMC 1566130.PMID 10455277.
  6. ^Paul P, Lahaye C, Delagrange P, Nicolas JP, Canet E, Boutin JA (July 1999)."Characterization of 2-[125I]iodomelatonin binding sites in Syrian hamster peripheral organs".The Journal of Pharmacology and Experimental Therapeutics.290 (1):334–40.doi:10.1016/S0022-3565(24)34904-3.PMID 10381796.
  7. ^abTosini G., Ye K. & Iuvone PM (2012)."Neuroprotection, neurogenesis, and the sleepy brain".Neuroscientist.18 (6):645–653.doi:10.1177/1073858412446634.PMC 3422380.PMID 22585341.
  8. ^abOxenkrug G. & Ratner R. (2012)."N-acetylserotonin and aging-associated cognitive impairment and depression".Aging Dis.3 (4):330–338.PMC 3501368.PMID 23185714.
  9. ^abSompol P.; Liu X.; Baba K.; Paul KN.; Tosini G.; Iuvone PM.; Ye K. (2011)."N-acetylserotonin promotes hippocampal neuroprogenitor cell proliferation in sleep-deprived mice".Proc. Natl. Acad. Sci. U.S.A.108 (21):8844–9.Bibcode:2011PNAS..108.8844S.doi:10.1073/pnas.1105114108.PMC 3102377.PMID 21555574.
  10. ^Oxenkrug G (2005). "Antioxidant effects of N-acetylserotonin: possible mechanisms and clinical implications".Ann. N. Y. Acad. Sci.1053 (1):334–47.Bibcode:2005NYASA1053..334O.doi:10.1111/j.1749-6632.2005.tb00042.x.PMID 16179540.S2CID 94273958.
  11. ^Gavazza MB.; Català A. (2004). "Protective effect of N-acetyl-serotonin on the nonenzymatic lipid peroxidation in rat testicular microsomes and mitochondria".J. Pineal Res.37 (3):153–60.doi:10.1111/j.1600-079x.2004.00150.x.PMID 15357659.S2CID 6974587.
  12. ^Wölfler A.; Abuja PM.; Schauenstein K.; Liebmann PM. (1999). "N-acetylserotonin is a better extra- and intracellular antioxidant than melatonin".FEBS Lett.449 (2–3):206–10.Bibcode:1999FEBSL.449..206W.doi:10.1016/s0014-5793(99)00435-4.PMID 10338133.S2CID 32077728.
  13. ^Peter Klemm; Markus Hecker; Hannelore Stockhausen; Chin Chen Wu; Christoph Thiemermann (Aug 1995)."Inhibition by N-acetyl-5-hydroxytryptamine of nitric oxide synthase expression in cultured cells and in the anaesthetized rat".Br J Pharmacol.115 (7):1175–1181.doi:10.1111/j.1476-5381.1995.tb15021.x.PMC 1908794.PMID 7582541.
  14. ^Perianayagam MC.; Oxenkrug GF.; Jaber BL. (2005). "Immune-modulating effects of melatonin, N-acetylserotonin, and N-acetyldopamine".Ann. N. Y. Acad. Sci.1053:386–93.doi:10.1111/j.1749-6632.2005.tb00046.x.PMID 16179544.S2CID 592935.
  15. ^abcOxenkrug GF (1999). "Antidepressive and antihypertensive effects of MAO-A inhibition: role of N-acetylserotonin. A review".Neurobiology (Budapest, Hungary).7 (2):213–24.PMID 10591054.
  16. ^abOxenkrug GF (1997). "[N-acetylserotonin and hypotensive effect of MAO-A inhibitors]".Voprosy Meditsinskoi Khimii (in Russian).43 (6):522–6.PMID 9503569.
  17. ^"N-Acetyl Serotonin". DrugBank.
Amino acid-derived
Major excitatory /
inhibitory systems
Glutamate system
GABA system
Glycine system
GHB system
Biogenic amines
Monoamines
Trace amines
Others
Neuropeptides
Lipid-derived
Endocannabinoids
Neurosteroids
Nucleobase-derived
Nucleosides
Adenosine system
Vitamin-derived
Miscellaneous
Cholinergic system
Gasotransmitters
Candidates
Catecholamines
Anabolism
Catabolism
Dopamine
Norepinephrine
Epinephrine
TryptophanSerotonin
Anabolism
Catabolism
SerotoninMelatonin
Trace amines
Histamine
GABA
Food antioxidants
Fuel antioxidants
Measurements
Angiopoietin
CNTF
EGF (ErbB)
EGF
(ErbB1/HER1)
ErbB2/HER2
ErbB3/HER3
ErbB4/HER4
FGF
FGFR1
FGFR2
FGFR3
FGFR4
Unsorted
HGF (c-Met)
IGF
IGF-1
IGF-2
Others
LNGF (p75NTR)
PDGF
RET (GFL)
GFRα1
GFRα2
GFRα3
GFRα4
Unsorted
SCF (c-Kit)
TGFβ
Trk
TrkA
TrkB
TrkC
VEGF
Others
MT1Tooltip Melatonin receptor 1
MT2Tooltip Melatonin receptor 2
Unsorted
Tryptamines
4-Hydroxytryptamines
andesters/ethers
5-Hydroxy- and
5-methoxytryptamines
N-Acetyltryptamines
α-Alkyltryptamines
Cyclized tryptamines
Isotryptamines
Related compounds
Retrieved from "https://en.wikipedia.org/w/index.php?title=N-Acetylserotonin&oldid=1323804900"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp